Today in Health Affairs Forefront, Jeffrey Kang and coauthors respond to two recent Forefront articles and argue that, rather than abandoning disease-based risk adjustment in Medicare Advantage, CMS should address coding intensity issues and continue to move to physician-reported encounter data.

Mark Fendrick writes that prior authorization should be targeted to the identification and prevention of services that do not produce improved clinical outcomes.

Jacquelyn Chou and coauthors argue that appropriately recognizing and accounting for the benefits of antiviral treatment in economic evaluations is important to encouraging the future innovation we may need for the next viral pandemic.

Laura Keohane and Ann Hwang highlight and analyze the Medicaid and CHIP Payment and Access Commission's recommendations for states to develop strategies for integrating Medicaid and Medicare coverage for dually eligible beneficiaries.

Currently, more than 70 percent of our content is freely available — and we’d like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.